Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
During 1985–1990 the U.S. National Cancer Institute (NCI) phased out its murine leukemia P388 anticancer drug screening program and developed as the replacement a new in vitro primary screen based upon a diverse panel of human tumor cell lines. For each substance tested, the screen generates a remarkably reproducible and characteristic profile of differential in vitro cellular sensitivity, or lack thereof, across the 60 different cell lines comprising the panel. Several investigational approaches to display, analysis, and interpretation of such profiles and databases, derived from the testing of tens of thousands of substances during the past 4–5 years since the NCI screen became fully operational, have been explored. A variety of useful, practical applications of the in vitro screen have become apparent. As these applications continue to evolve, they are proving to be complementary to diverse other anticancer screening and drug discovery strategies being developed or pursued elsewhere. Reviewed herein are some practical considerations and selected specific examples, particularly illustrating research applications of the NCI screen that may be more broadly applicable to the search for new anticancer drug development leads with novel profiles of antitumor activity and/or mechanisms of action. © 1995 Wiley‐Liss, Inc. This article is a US Government work and, as such, is in the public domain in the United States of America.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in December 1992, MDA‐MB‐435 was added to the NCI‐60 cell line panel for use in anticancer drug screening, where it was initially described as a “breast” cancer cell line.17”
From Authentication of M14 melanoma cell line proves misidentification of MDA‐MB‐435 breast cancer cell line (2018) · cites this paper as [17]
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Self-citationMonks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Self-citationA Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn, M. E., Ks, N., Ohnuki, Y., Lechner, J. F., & Jones, L. W. (1979) · PubMed · Cited by 2,121
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., & Boyd, M. R. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.14.1088 · Cited by 967
Self-citationRubinstein, L. V., Shoemaker, R. H., Paull, K. D., Simon, R. M., Tosini, S., Skehan, P., Scudiero, D. A., Monks, A., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1113 · Cited by 927
Self-citationIsolation of a human prostate carcinoma cell line (DU 145)
Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., & Paulson, D. F. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910210305 · Cited by 926
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Establishment and characterization of a cell line of human breast carcinoma origin
Keydar, I., Chen, L., Karby, S., Weiss, F. R., Delarea, J., Radu, M., Chaitcik, S., & Brenner, H. J. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90139-7 · Cited by 650
Research works printed but not linked: 6
- Acton EM, 1992, Anticancer specificity of some ellipticinium salts against human brain tumors in vitro, Proc Am Assoc Cancer Res, 33, 488
- Boyd MR, 1986, Accomplishments in Oncology, Vol 1, Cancer Therapy: Where Do We Go From Here?, 68
- Boyd MR, 1989, Cancer: Principles and Practice of Oncology Updates, 1
- Buolamwini JK, 1994, Searching for new molecular targets for therapy of cancer and AIDS: Characterization by 2D protein gel electrophoresis, Proc Am Assoc Cancer Res, 35, 613
- Grever MR, 1994, Status of in vivo evaluations in the NCI anticancer drug discovery program, Proc Am Assoc Cancer Res, 35, 369
- Stinson SF, 1992, Morphologic and immunocytochemical characteristics of human tumor cell lines for use in an anticancer drug screen, Anticancer Res, 12, 1035
Cited by
Items 501–600 of 1,000
El‐Azab, A. S., Abdel‐Aziz, A. A. ‐., Ghabbour, H. A., & El-Gendy, M. A. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1368504 · Cited by 37
Kassab, A. E., & Hassan, R. A. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.07.008 · Cited by 37
Quinoline‐1,3‐Oxazole Hybrids: Syntheses, Anticancer Activity and Molecular Docking Studies
Shah, S. R., Katariya, K., & Reddy, D. (2020) · ChemistrySelect · doi:10.1002/slct.201903763 · Cited by 37
PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis
Feizi, N., Nair, S. K., Smirnov, P., Beri, G., Eeles, C. B., Esfahani, P. N., Nakano, M., Tkachuk, D., Mammoliti, A., Gorobets, E., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1084 · Cited by 39
Wang, H., Li, Z., Chen, X., Wong, J. J., Bi, T., Tong, X., Xu, Z., Zhen, M., Wan, Y., Li, T., et al. (2022) · Chem · doi:10.1016/j.chempr.2022.10.019 · Cited by 37
Emam, S. H., Hassan, R. A., Osman, E. O., Hamed, M. I. A., Abdou, A. M., Kandil, M. M., Elbaz, E. M., & Mikhail, D. S. (2023) · Drug Development Research · doi:10.1002/ddr.22037 · Cited by 40
Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines
Temburnikar, K. W., Zimmermann, S. C., Kim, N. T., Ross, C. R., Gelbmann, C. B., Salomon, C. E., Wilson, G. M., Balzarini, J. M., & Seley‐Radtke, K. L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.033 · Cited by 37
Supek, F., Ramljak, T. Š., Marjanović, M., Buljubašić, M., Kragol, G., Ilić, N., Šmuc, T., Zahradka, D., Mlinarić‐Majerski, K., & Kralj, M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.009 · Cited by 37
Çıkla‐Süzgün, P., Tatar, E., Küçükgüzel, İ., Şahin, F., Yurdakul, D., Basu, A., Krishnan, R., Nichols, D. B., Kaushik‐Basu, N., & Küçükgüzel, Ş. G. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0550-3 · Cited by 37
Alabsi, A. M., Lim, K. L., Paterson, I. C., Ali-Saeed, R., & Moharram, B. A. (2016) · BioMed Research International · doi:10.1155/2016/4904016 · Cited by 37
Synthesis of 1-(ω-aminoalkyl)naphthoindolediones with antiproliferative properties
Shchekotikhin, A. E., Buyanov, V. N., & PREOBRAZHENSKAYA, M. N. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.04.042 · Cited by 37
Bansal, R., Guleria, S., Thota, S., Bodhankar, S. L., Patwardhan, M. R., Zimmer, C., Hartmann, R. W., & Harvey, A. L. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.005 · Cited by 39
Elkamhawy, A., Park, J., Cho, N., Sim, T., Pae, A. N., & Roh, E. J. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1004057 · Cited by 36
Synthesis and evaluation of anticancer activity of 6-pyrazolinylcoumarin derivatives
Garazd, Y., Garazd, M. M., & Lesyk, R. (2016) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2016.05.005 · Cited by 36
Jones, W. P., ECHEVERRI, T. L., Mi, Q., Chai, H., Lee, D., Soejarto, D. D., Cordell, G. A., Pezzuto, J. M., Swanson, S. M., & Kinghorn, A. D. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.57.9.0005 · Cited by 36
Septisetyani, E. P., Ningrum, R. A., Romadhani, Y., Wisnuwardhani, P. H., & Santoso, A. (2014) · INDONESIAN JOURNAL OF PHARMACY · doi:10.14499/indonesianjpharm25iss4pp245 · Cited by 36
Dallemagne, P., Khanh, L. P., ALSAIDI, A., Renault, O., Varlet, I., Collot, V., Bureau, R., & Rault, S. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00070-6 · Cited by 36
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides
Cocco, M. T., Congiu, C., & Onnis, V. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00465-0 · Cited by 36
Synthesis, anticancer and antiviral activities of novel thiopyrano[2,3-d]thiazole-6-carbaldehydes
Lozynskyi, A., Holota, S. M., Zimenkovsky, B. S., Atamanyuk, D. V., Gzella, A. K., & Lesyk, R. (2016) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426507.2016.1166108 · Cited by 36
Rida, S. M., Ashour, F. A., El-Hawash, S. A., El‐Semary, M. M., & Badr, M. H. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600118 · Cited by 36
International Journal of Chemistry and Pharmaceutical Sciences
Dhani, P. R. (2014) · ADVANCED SCIENCES INDEX · Cited by 36
Abualhasan, M., Hawash, M., Aqel, S., Al-Masri, M. Y., Mousa, A., & Issa, L. (2023) · ACS Omega · doi:10.1021/acsomega.3c05695 · Cited by 35
Texas Native Plants Yield Compounds with Cytotoxic Activities against Prostate Cancer Cells
Shaffer, C. V., Cai, S., Peng, J., Robles, A. J., Hartley, R., Powell, D. R., Du, L., Cichewicz, R. H., & Mooberry, S. L. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00908 · Cited by 38
Hassan, R. A., Hamed, M. I. A., Abdou, A. M., & El‐Dash, Y. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105861 · Cited by 35
Kumar, J., Dhar, P., Tayade, A. B., Gupta, D., Chaurasia, O. P., Upreti, D. K., Toppo, K., Arora, R., Suseela, M. R., & Srivastava, R. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118255 · Cited by 37
Edrees, M. M., Farghaly, T. A., El‐Hag, F. A. A., & Abdalla, M. M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.026 · Cited by 35
Basarić, N., Cindro, N., Bobinac, D., Mlinarić‐Majerski, K., Uzelac, L., Kralj, M., & Wan, P. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05182b · Cited by 35
El‐Azab, A. S., Alanazi, A. M., Abdel-Aziz, N. I., Al-Suwaidan, I. A., El‐Sayed, M. A. ‐., El‐Sherbeny, M. A., & Abdel‐Aziz, A. A. ‐. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0230-8 · Cited by 36
Luzina, E. L., & Popov, A. V. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.09.019 · Cited by 35
Synthesis of New Artemisinin-Derived Dimers by Self-Cross-Metathesis Reaction
Grellepois, F., Crousse, B., Bonnet‐Delpon, D., & Bégué, J. (2005) · Organic Letters · doi:10.1021/ol052056+ · Cited by 35
Atamanyuk, D. V., Zimenkovsky, B., Atamanyuk, V., Nektegayev, I., & Lesyk, R. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1301-13 · Cited by 35
Kunick, C., Bleeker, C., Prühs, C., Totzke, F., Schächtele, C., Kubbutat, M. H. G., & Link, A. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.071 · Cited by 35
Roaiah, H. M. F., Ghannam, I. A. Y., Ali, I. H., Kerdawy, A. M. E., Ali, M. M., Abbas, S. E.-S., & El‐Nakkady, S. S. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201700299 · Cited by 35
Feng, C., Chen, N., Wen, Z., Yang, W.-Y., Kuo, H., Sung, P., Su, J., Cheng, S.-Y., & Chen, W.-F. (2019) · Marine Drugs · doi:10.3390/md17060315 · Cited by 35
Eldehna, W. M., Abdelrahman, M. A., Nocentini, A., Bua, S., Al‐Rashood, S. T., Hassan, G. S., Bonardi, A., Almehizia, A. A., Alkahtani, H. M., Alharbi, A., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103102 · Cited by 35
Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines
Boegsted, M., Holst, J. M., Fogd, K., Falgreen, S., Sørensen, S., Schmitz, A., Bukh, A., Johnsen, H. E., Nyegaard, M., & Dybkær, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019322 · Cited by 34
Seif, S. E., Mahmoud, Z., Wardakhan, W. W., Abdou, A. M., & Hassan, R. A. (2023) · Drug Development Research · doi:10.1002/ddr.22058 · Cited by 35
Osman, E. O., Emam, S. H., Sonousi, A. S. M., Kandil, M. M., Abdou, A. M., & Hassan, R. A. (2023) · Drug Development Research · doi:10.1002/ddr.22060 · Cited by 34
Helwa, A. A., El‐Dydamony, N. M., Radwan, R. A., Abdelraouf, S. M., & Abdelnaby, R. M. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104051 · Cited by 35
Mohammed, E. R., & Elmasry, G. F. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2036985 · Cited by 34
Anti-cancer activity of carbamate derivatives of melampomagnolide B
Janganati, V., Penthala, N. R., Madadi, N. R., Chen, Z., & Crooks, P. A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.059 · Cited by 34
Abd‐Elzaher, M. M., Labib, A. A., Mousa, H. A., Moustafa, S. A., & Abdallah, M. M. (2013) · Research on Chemical Intermediates · doi:10.1007/s11164-013-1090-7 · Cited by 34
Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer
Trafalis, D. T., Geromichalos, G. D., Koukoulitsa, C., Papageorgiou, T., Karamanakos, P., & Camoutsis, C. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9083-x · Cited by 35
Cvek, B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00005-5 · Cited by 39
Ibrahim, H. S., Albakri, M. E., Mahmoud, W. R., Allam, H. A., Reda, A. M., & Abdel‐Aziz, H. A. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.01.006 · Cited by 34
Singh, I., Luxami, V., & Paul, K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.042 · Cited by 34
Jonsson, E. W., Dhar, S., Jönsson, B., Nygren, P., Graf, W. D., & Larsson, R. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00289-6 · Cited by 34
Leese, M. P., Newman, S. P., Purohit, A., Reed, M. J., & Potter, B. V. L. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.04.027 · Cited by 34
Freije, J. M. P., Lawrence, J. A., Hollingshead, M. G., Rosa, A. D. L., Narayanan, V. L., Grever, M. R., Sausville, E. A., Paull, K. D., & Steeg, P. S. (1997) · Nature Medicine · doi:10.1038/nm0497-395 · Cited by 34
Self-citationCytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds
Vashishtha, S. C., Zello, G. A., Nienaber, K. H., Balzarini, J. M., Clercq, E. D., Stables, J. P., & Dimmock, J. R. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.09.011 · Cited by 33
Rostom, S. A. F., Badr, M. H., Razik, H. A. A. E., & Ashour, H. M. A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.053 · Cited by 33
Discovery of Hybrid Purine-quinoline Molecules and Their Cytotoxic Evaluation
Kapadiya, K. M., & Khunt, R. (2018) · Letters in Drug Design & Discovery · doi:10.2174/1570180815666180419151742 · Cited by 33
Design and Synthesis of Some β-Carboline Derivatives as Multi-Target Anticancer Agents
Abdelsalam, M. A. M., Aboulwafa, O. M., BADAWEY, E. ‐. A. M., El-Shoukrofy, M. S., El-Miligy, M. M. M., & Gouda, N. A. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0226 · Cited by 33
Akhtar, W., Nainwal, L. M., Khan, M. F., Verma, G., Chashoo, G., Bakht, M. A., Iqbal, M., Akhtar, M., Shaquiquzzaman, M., & Alam, M. M. (2020) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2020.109579 · Cited by 33
Cushman, M. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01491 · Cited by 34
Chaudhari, P. J., Bari, S. B., Surana, S. J., Shirkhedkar, A. A., Bonde, C. G., Khadse, S. C., Ugale, V. G., Nagar, A. A., & Cheke, R. S. (2022) · ACS Omega · doi:10.1021/acsomega.2c01198 · Cited by 33
New chondropsin macrolide lactams from marine sponges in the genus Ircinia
Rashid, M. A., Gustafson, K. R., & Boyd, M. R. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)02348-0 · Cited by 33
Self-citationSynthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines
Shinkre, B. A., Raisch, K. P., Fan, L., & Velu, S. E. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.051 · Cited by 33
Han, X., Li, C., Mosher, M. D., Rider, K. C., Zhou, P., Crawford, R. L., Fusco, W. G., Paszczynski, A. J., & Natale, N. R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.056 · Cited by 33
Madden (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.888 · Cited by 33
Masaldan, S., & Iyer, V. V. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2838 · Cited by 34
Synthesis and anticancer activity of 6-heteroarylcoumarins
Galayev, O., Garazd, Y., Garazd, M. M., & Lesyk, R. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.021 · Cited by 33
Singla, P., Luxami, V., & Paul, K. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.083 · Cited by 33
Pyrazino[1,2-b]isoquinolines: Synthesis and study of their cytostatic and cytotoxic properties
Ortín, I., González, J. F., de la Cuesta, E., Manguán-García, C., Perona, R., & Avendaño, C. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.083 · Cited by 33
HTS384 NCI60: The Next Phase of the NCI60 Screen
Kunkel, M. W., Coussens, N. P., Morris, J., Taylor, R. C., Dexheimer, T. S., Jones, E. M., Doroshow, J. H., & Teicher, B. A. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3031 · Cited by 32
Fadaly, W. A. A., Nemr, M. T. M., El-Hameed, A. M. A., Mohamed, F. E. A., & Zidan, T. H. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108563 · Cited by 34
Ona, T., & Shibata, J. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4223-5 · Cited by 35
Risinger, A. L., Dybdal‐Hargreaves, N. F., & Mooberry, S. L. (2015) · PubMed · Cited by 32
Perković, I., Antunović, M., Marijanović, I., Pavić, K., Ester, K., Kralj, M., Vlainić, J., Kosalec, I., Schols, D., Hadjipavlou‐Litina, D., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.021 · Cited by 32
Synthesis and Anticancer Activity of Some Fused Heterocyclic Compounds Containing Pyrazole Ring
Hassan, A. Y., Mohamed, M. A., Abdel‐Aziem, A., & Hussain, A. O. (2020) · Polycyclic aromatic compounds · doi:10.1080/10406638.2020.1764984 · Cited by 32
Kazakova, O. B., Giniyatullina, G. V., Газизьянович, М. А., Babkov, D. A., Sokolova, E. V., & Спасов, А. А. (2020) · Molecules · doi:10.3390/molecules25204833 · Cited by 32
Al‐Saadi, M. S., Rostom, S. A. F., & Faidallah, H. M. (2008) · Archiv der Pharmazie · doi:10.1002/ardp.200700178 · Cited by 32
Bérubé, G., Rabouin, D., Perron, V., N’Zemba, B., -Gaudreault, R., Parent, S., & Asselin, É. (2006) · Steroids · doi:10.1016/j.steroids.2006.06.007 · Cited by 32
Luzina, E. L., & Popov, A. V. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.057 · Cited by 32
Hossain, M. I., Świtalska, M., Peng, W. J., Takashima, M., Wang, N., Kaiser, M., Wietrzyk, J., Dan, S., Yamori, T., & Inokuchi, T. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.08.008 · Cited by 32
Antypenko, L., Kovalenko, S. I., Antypenko, O. M., Моисеевич, К. А., & Achkasova, O. M. (2013) · Scientia Pharmaceutica · doi:10.3797/scipharm.1208-13 · Cited by 32
Luzina, E. L., & Popov, A. V. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.026 · Cited by 32
Targeting the Loss of the von Hippel-Lindau Tumor Suppressor Gene in Renal Cell Carcinoma Cells
Sutphin, P. D., Chan, D. A., Li, J. M., Turcotte, S., Krieg, A. J., & Giaccia, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0604 · Cited by 36
Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus Zyzzya
Dijoux‐Franca, M., Schnabel, P. C., Hallock, Y. F., Boswell, J. L., Johnson, T. R., Wilson, J. A., Ireland, C. M., van Soest, R. W. M., Boyd, M. R., Barrows, L. R., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.019 · Cited by 32
Self-citationSynthesis of some new biologically active thiadiazolotriazinones—Part II
Holla, B. S., Sarojini, B. K., Shridhara, K., & Antony, G. (1999) · Il Farmaco · doi:10.1016/s0014-827x(99)00008-7 · Cited by 32
Lansiaux, A., Léonce, S., Kraus‐Berthier, L., Mahieu, C., Mazinghien, R., Didier, S., David‐Cordonnier, M., Hautefaye, P., Lavielle, G., Bailly, C., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.034637 · Cited by 34
Wallqvist, A., Rabow, A. A., Shoemaker, R. H., Sausville, E. A., & Covell, D. G. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg302 · Cited by 32
New bis-N9-(methylphenylmethyl)purine derivatives: Synthesis and antitumor activity
Kode, N. R., Chen, L., Murthy, D., Adewumi, D., & Phadtare, S. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.10.017 · Cited by 32
Synthesis and evaluation of functionalized indoles as antimycobacterial and anticancer agents
Cihan‐Üstündağ, G., & Çapan, G. (2012) · Molecular Diversity · doi:10.1007/s11030-012-9385-y · Cited by 31
New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents
Demirayak, Ş., Yurttaş, L., Gündoğdu-Karaburun, N., Karaburun, A. Ç., & Kayağil, İ. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.04.040 · Cited by 31
Lozynskyi, A., Zimenkovsky, B. S., Radko, L., Stypuła-Trębas, S., Roman, O., Gzella, A. K., & Lesyk, R. (2017) · Chemical Papers · doi:10.1007/s11696-017-0318-1 · Cited by 31
Nam, W., Chen, H., Ren, X., Agah, M., Kim, I., & Zhou, W. M. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c01644 · Cited by 31
Heterocycles in Breast Cancer Treatment: The Use of Pyrazole Derivatives
Ardevines, S., Marqués‐López, E., & Herrera, R. P. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829091830 · Cited by 32
Elanany, M. A., Osman, E. E. A., Gedawy, E. M., & Abou‐Seri, S. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-30885-5 · Cited by 34
Santiago-Vázquez, Y., Das, S., Das, U., Robles‐Escajeda, E., Ortega, N. M., Lema, C., Varela-Ramírez, A., Aguilera, R. J., Balzarini, J. M., Clercq, E. D., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.009 · Cited by 31
Dhorajiya, B. D., Dholakiya, B. Z., & Mohareb, R. M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0973-5 · Cited by 31
Jha, A., Mukherjee, C., Prasad, A. K., Parmar, V. S., Clercq, E. D., Balzarini, J. M., Stables, J. P., Manavathu, E. K., Shrivastav, A., Sharma, R. K., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.065 · Cited by 31
SYNTHESIS OF SOME NEW 1,2,4-TRIAZOLO[3,4-b]-THIADIAZOLE DERIVATIVES AS POSSIBLE ANTICANCER AGENTS
Bhat, K. S., Prasad, D. J., Boja Poojary, B., & Holla, B. S. (2004) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426500490464186 · Cited by 31
Kamal, A., Gayatri, N. L., Reddy, D. R., Reddy, P. S. M. M., Arifuddin, M., Dastidar, S. G., Kondapi, A. K., & Rajkumar, M. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.032 · Cited by 31
El‐Messery, S. M., Hassan, G. S., Nagi, M. N., Habib, E. E., Al‐Rashood, S. T., & El‐Subbagh, H. I. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.022 · Cited by 31
Anti-proliferative activities of 32 Malaysian plant species in breast cancer cell LINES
Nurhanan, M. Y., Asiah, O., Adenan, M. I., Syarifah, M. M. S., Norhayati, I., & Sahira, H. L. (2008) · JOURNAL OF TROPICAL FOREST SCIENCE · Cited by 31
CDK1‐Inhibitory Activity of Paullones Depends on Electronic Properties of 9‐Substituents
Pies, T., Schaper, K., Leost, M., Zaharevitz, D. W., Gussio, R., Meijer, L., & Kunick, C. (2004) · Archiv der Pharmazie · doi:10.1002/ardp.200300870 · Cited by 34
Singh, P., Kaur, P., Luxami, V., Kaur, S., & Kumar, S. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.01.018 · Cited by 31
Natural Products Drug Discovery and Development at the United States National Cancer Institute
Cragg, G. M. L., & Newman, D. J. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1455-8_3 · Cited by 32
Abdelazeem, A. H., Alqahtani, A. M., Omar, H. A., Bukhari, S. N. A., & Gouda, A. M. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128567 · Cited by 30
Metadata
- Authors
- Boyd, M. R., & Paull, K. D.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- National Cancer Institute (US)
- Corresponding author
- Boyd, Michael R.
- ORCID
- Boyd, Michael R.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 34
- Issue
- 2
- Pages
- 91-109
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2118909720
- Cited by
- 1,572
- References
- 40
- Citations by year
- 2026: 28 · 2025: 57 · 2024: 79 · 2023: 58 · 2022: 68 · 2021: 81 · 2020: 74 · 2019: 51 · 2018: 58 · 2017: 39 · 2016: 56 · 2015: 61 · 2014: 78 · 2013: 84 · 2012: 79
- FWCI
- 30.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Development Research (publishedVersion, public-domain)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- anticancer drug discovery, human cancer cell lines, anticancer activity, lead compound identification, mechanism of action
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.